Literature DB >> 23157810

Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

Dirk De Bacquer1, Jean Dallongeville, Kornelia Kotseva, Marie Therese Cooney, Andrzej Pajak, Jaap W Deckers, Otto Mayer, Diego Vanuzzo, Seppo Lehto, Zlatko Fras, Erika Östor, Giovanni B Ambrosio, Guy De Backer, David Wood, Ulrich Keil, Susana Sans, Ian Graham, Kalevi Pyörälä.   

Abstract

BACKGROUND: The EUROASPIRE I, II and III surveys revealed high prevalences of modifiable risk factors in the high priority group of coronary patients all over Europe. The potential to further reduce coronary heart disease (CHD) morbidity and mortality rates is still considerable. We report here on the relative risk of cardiovascular disease (CVD) death associated with common modifiable risk factor levels based on the mortality follow-up of patients participating in the first two EUROASPIRE surveys. We also present a novel simple risk classification system (ERC) that can be used in the management of patients with existing CHD.
METHODS: The study cohort consisted of a consecutive sample of CHD patients aged ≤ 70 years from 12 European countries. Baseline data gathered in 1995-2000 through standardized methods, were linked to cardiovascular mortality in 5216 patients according to an accelerated failure time model.
RESULTS: During 28,143 person-years of follow-up, 332 patients died from cardiovascular disease denoting a CVD mortality risk of 12.3 per 1000 person-years in men and 10.2 per 1000 person-years in women. In multivariate analysis, fasting glucose, total cholesterol and smoking emerged as the strongest independent modifiable predictors of cardiovascular mortality.
CONCLUSIONS: The results of the mortality follow-up of the EUROASPIRE I and II CHD patients emphasize the continuing risk from elevated glucose and total cholesterol levels and underline the importance of smoking cessation in secondary prevention. The ERC risk tool that we developed may prove helpful to obtain these goals in the setting of secondary prevention.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Coronary heart disease; Epidemiology; Secondary prevention

Mesh:

Year:  2012        PMID: 23157810     DOI: 10.1016/j.ijcard.2012.10.051

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  12 in total

1.  Implementation of Cardiovascular Disease Prevention Guidelines in Clinical Practice-Can We Do Better?

Authors:  Kornelia Kotseva
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

2.  Emergent biomarkers of residual cardiovascular risk in patients with low HDL-c and/or high triglycerides and average LDL-c concentrations: focus on HDL subpopulations, Oxidized LDL, adiponectin, and uric acid.

Authors:  Filipa Mascarenhas-Melo; Filipe Palavra; Daniela Marado; José Sereno; Edite Teixeira-Lemos; Isabel Freitas; Maria Isabel-Mendonça; Rui Pinto; Frederico Teixeira; Flávio Reis
Journal:  ScientificWorldJournal       Date:  2013-11-04

3.  Practice setting and secondary prevention of coronary artery disease.

Authors:  Piotr Jankowski; Danuta Czarnecka; Leszek Badacz; Piotr Bogacki; Jacek S Dubiel; Janusz Grodecki; Tomasz Grodzicki; Janusz Maciejewicz; Ewa Mirek-Bryniarska; Jadwiga Nessler; Wiesław Piotrowski; Piotr Podolec; Wanda Śmielak-Korombel; Wiesława Tracz; Kalina Kawecka-Jaszcz; Andrzej Pająk
Journal:  Arch Med Sci       Date:  2017-01-19       Impact factor: 3.318

4.  Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations.

Authors:  Maria Sakalaki; Salim Barywani; Annika Rosengren; Lena Björck; Michael Fu
Journal:  BMC Cardiovasc Disord       Date:  2019-11-06       Impact factor: 2.298

5.  Compliance to secondary prevention strategies for coronary artery disease: a hospital-based cross-sectional survey from Ernakulam, South India.

Authors:  Remya Sudevan; Damodaran Vasudevan; Manu Raj; Rajesh Thachathodiyl; Maniyal Vijayakumar; Jabir Abdullakutty; Paul Thomas; Vijo George; Conrad Kabali
Journal:  BMJ Open       Date:  2020-10-10       Impact factor: 2.692

6.  Lipid profile and prognosis in patients with coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Xiangmei Zhao; Dongying Wang; Lijie Qin
Journal:  BMC Cardiovasc Disord       Date:  2021-02-03       Impact factor: 2.298

7.  Five-Year Residual Atherosclerotic Cardiovascular Disease Risk Prediction Model for Statin Treated Patients With Known Cardiovascular Disease.

Authors:  Nathan D Wong; Yanglu Zhao; Pin Xiang; Blai Coll; J Antonio G López
Journal:  Am J Cardiol       Date:  2020-09-28       Impact factor: 2.778

8.  Implication of low HDL-c levels in patients with average LDL-c levels: a focus on oxidized LDL, large HDL subpopulation, and adiponectin.

Authors:  Filipa Mascarenhas-Melo; José Sereno; Edite Teixeira-Lemos; Daniela Marado; Filipe Palavra; Rui Pinto; Petronila Rocha-Pereira; Frederico Teixeira; Flávio Reis
Journal:  Mediators Inflamm       Date:  2013-10-24       Impact factor: 4.711

9.  A web-based peer-modeling intervention aimed at lifestyle changes in patients with coronary heart disease and chronic back pain: sequential controlled trial.

Authors:  Rebecca Schweier; Matthias Romppel; Cynthia Richter; Eike Hoberg; Harry Hahmann; Inge Scherwinski; Gregor Kosmützky; Gesine Grande
Journal:  J Med Internet Res       Date:  2014-07-23       Impact factor: 5.428

10.  Cardiac Rehabilitation in Real Life.

Authors:  Piotr Jankowski; Andrzej Pajak; Radoslaw Lysek; Anna Lukaszewska; Renata Wolfshaut-Wolak; Piotr Bogacki; Janusz Grodecki; Ewa Mirek-Bryniarska; Jadwiga Nessler; Piotr Podolec; Kalina Kawecka-Jaszcz; Danuta Czarnecka
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.